CV/COS Webinar: Clip 16

During the insightful discussion, the potential use of real-world data for a synthetic control arm in clinical trials was explored. Carevive’s commitment to adhering to regulatory standards for electronic data capture sets a strong foundation for future opportunities in optimizing this data for regulatory interactions. While no definitive commitments can be made, the increasing patient numbers and rigorous methods prioritized by Carevive offer hope for real-world data to play a significant role in regulatory decision-making. Collaborating with Aaron and his team, Carevive aims to contribute to the advancement of oncology research and elevate patient outcomes through the integration of real-world evidence.

Recent Episodes

Healthcare systems are under pressure almost everywhere, but the strain is especially visible in lower-resource settings where demand is rising faster than infrastructure. In Pakistan, that pressure is playing out across a system that has to serve more than 250 million people with limited public investment. Public health spending remains below 1% of GDP,…

Medicine isn’t what it used to be—not for the people practicing it. Independent physicians are becoming the exception, not the norm, as more doctors move into hospital systems, corporate groups, and academic networks. At the same time, the pipeline of specialists isn’t keeping pace with growing patient needs, particularly in complex fields like vascular…

Healthcare isn’t short on strategy right now—it’s short on people, access, and experienced leadership where it matters most. In Texas alone, more rural hospitals have closed than in any other state over the past decade, leaving entire communities with limited access to care. At the same time, many health systems are realizing they haven’t…